酪酸梭菌活菌片防治婴幼儿肺炎继发性腹泻疗效观察

Efficacy of Clostridium Butyricum Tablets in prevention and treatment of infants with pneumonia secondary diarrhea

目的观察微生态制剂酪酸梭菌活菌片防治婴幼儿肺炎继发性腹泻的疗效。方法将204例婴幼儿肺炎患儿随机分为治疗组和对照组,各102例,均采用相同的基础治疗,治疗组在入院当日加用酪酸梭菌活菌片,出现腹泻后仍继续用,对照组在出现腹泻后加用蒙脱石散。结果治疗组继发腹泻22例(21.57%),对照组继发腹泻43例(42.16%),差异有高度统计学意义(Ρ<0.01)。对继发性腹泻的疗效比较,治疗组明显优于对照组,差异有统计学意义(Ρ<0.05)。结论微生态制剂酪酸梭菌活菌片能降低婴幼儿肺炎继发性腹泻的发生率,对继发性腹泻的治疗也有较好疗效。故推荐对于婴幼儿肺炎患儿进行抗生素治疗的同时,应常规使用微生态制剂来防治继发性腹泻。

Objective To observe the efficacy of proboscis Clostridium Butyricum Tablets for prevention and treatment of infants with pneumonia secondary diarrhea.Methods 204 infants with pneumonia were randomly divided into treatment group and control group,with 102 cases in each group.Both groups were adopted the same basic treatment,and the treatment group were added Clostridium Butyricum Tablets in the same day as admission to hospital,but the control group were added Montmorillonite Powder when they suffered from diarrhea.Results There are 22 patients（21.57%） of secondary diarrhea in treatment group,43 patients（42.16%） in control group（P 0.01）.In regard to the treatment efficacy of secondary diarrhea,the treatment group were significantly better than the control group（P 0.05）.Conclusion Clostridium Butyricum Tablets can reduce the incidence of infants with pneumonia secondary diarrhea,it also can treat secondary diarrhea effectively.Therefore,we recommend for infants with pneumonia adding micro ecological praeparatum except for antibiotics treatment in preventing and treating secondary diarrhea.